pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
371
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
cetoquagene parvec
Xerostomia
$MGTX
MeiraGTx Holdings plc
0
catalysts
Phase 3
civorebrutinib
civorebrutinib [INN]
Neuromyelitis Optica (Devic's Syndrome)
SinoMab Bioscience Ltd
0
catalysts
Phase 2
claseprubart
claseprubart[INN]
Myasthenia Gravis
Dianthus Therapeutics Inc
0
catalysts
← prev
page 9 of 13
next →
131
Pain
89
Neurology
1
Marketed
clemastine fumarate
Clemastine Fumarate (clemastine fumarate)
Chronic Urticaria
Genus Lifesciences Inc
0
catalysts
Marketed
clocortolone pivalate
Clocortolone Pivalate Dr.Reddy's (clocortolone pivalate)
Psoriasis
Dr. Reddy's Laboratories Ltd
0
catalysts
Marketed
conestat alfa
Ruconest (conestat alfa [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Pharming Healthcare, Inc.
0
catalysts
Marketed
corticotropin
Acthar (corticotropin [INN])
Membranous Glomerulonephritis
Cerium Pharmaceuticals Inc
0
catalysts
Marketed
cyproheptadine hydrochloride
Cyproheptadine Hydrochloride (cyproheptadine hydrochloride)
Vasomotor Rhinitis
Boscogen Inc
0
catalysts
Marketed
desoximetasone
Desoximetasone (desoximetasone)
Psoriasis
Teligent Inc
0
catalysts
Marketed
deucravacitinib
Sotyktu (deucravacitinib)
Psoriatic Arthritis
Bristol-Myers Squibb Co
0
catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCX
Quince Therapeutics, Inc.
0
catalysts
Marketed
dexchlorpheniramine maleate
RyClora (dexchlorpheniramine maleate)
Angioedema
Carwin Pharmaceutical Sales LLC
0
catalysts
Marketed
diclofenac potassium
Cataflam (diclofenac potassium)
Primary Dysmenorrhea
Amici Pharmaceuticals LLC
0
catalysts
Marketed
diflorasone diacetate
Diflorasone Diacetate (diflorasone diacetate)
Dermatosis
Avondale Pharmaceuticals LLC
0
catalysts
Marketed
diphenhydramine
Diphenhydramine Hydrochloride (diphenhydramine [INN])
Blood Plasma Hypersensitivity
Mylan Institutional Inc
0
catalysts
Marketed
dog [dander (Canis lupus familiaris) + hair (Canis lupus familiaris)] allergen extract
Dog Hair + Dander Canus Lupus Familaris Allergen
Dog Allergy
Jubilant HollisterStier LLC
0
catalysts
Marketed
donidalorsen sodium
Dawnzera (donidalorsen sodium)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Marketed
ecallantide
Kalbitor (ecallantide)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Dyax Corp
0
catalysts
Marketed
eculizumab
Soliris (eculizumab)
Paroxysmal Nocturnal Hemoglobinuria
Alexion Pharmaceuticals Inc
0
catalysts
pre_registration
efgartigimod alfa
Vyvgart (efgartigimod alfa)
Myasthenia Gravis
IgG receptor FcRn large subunit p51
$ARGX
ARGENX SE
0
catalysts
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease)
$ATYR
aTYR PHARMA INC
0
catalysts
Marketed
elapegademase
Revcovi (elapegademase-lvlr)
Adenosine Deaminase (ADA) Deficiency Related SCID
Leadiant Biosciences Inc
0
catalysts
Phase 3
envudeucitinib
Plaque Psoriasis (Psoriasis Vulgaris)
$ALMS
ALUMIS INC.
0
catalysts
Phase 2
epaldeudomide
epaldeudomide [INN]
Systemic Lupus Erythematosus
Kangpu Biopharmaceuticals Ltd
0
catalysts
Marketed
etanercept
Enbrel (etanercept)
Plaque Psoriasis (Psoriasis Vulgaris)
$AMGN
AMGEN INC
0
catalysts
Marketed
etodolac
Etodolac (etodolac)
Osteoarthritis Pain
Bayshore Pharmaceuticals LLC
0
catalysts
Preclinical
exRP-250
Psoriasis
exRNA Therapeutics Ltd
0
catalysts
Phase 3
felzartamab
felzartamab [INN]
Membranous Glomerulonephritis
$BIIB
BIOGEN INC.
0
catalysts
Marketed
fluocinonide
Fluocinonide Oceanside (fluocinonide)
Psoriasis
Oceanside Pharmaceuticals Inc
0
catalysts
Marketed
flurandrenolide
Flurandrenolide (flurandrenolide)
Psoriasis
PAI Holding Co LLC
0
catalysts
